Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03983369 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Low-level Laser Therapy in the Prevention of Chemotherapy-induced Mucositis in Children and Young Adults

Study acronym: MUCILA
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 6, 2026 (before its estimated August 28, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Site details revised at 1 of 5 sitesv5
  2. Notable Primary completion date: Sep 2023 to Aug 28, 2026
    • Study completion date: Sep 2023 to Sep 2026
    v4
  3. Notable Primary and study completion dates: Sep 2021 to Sep 2023v3 Show 4 more changesShow less
    • Enrollment target: 300 to 315
    • Study sites: 1 to 5
    • Eligibility criteria expanded, about 138 words
    • Study title shortened, about 5 words
  4. Notable Trial status: Active, Not Recruiting to Recruiting
    • Start date: Sep 12, 2018 to Aug 29, 2018
    • Eligibility criteria expanded, about 41 words
    • Site details revised
    v2
  5. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To assess the efficacy of preventive Low-Level Laser Therapy (LLLT) for reducing the incidence of WHO's grade 3-4 oral mucositis in children and young adults receiving chemotherapy regimens associated with a high rate of mucositis: conventional chemotherapy or High Dose Chemotherapy (HDC) conditioning regimens with Hematological Stem Cell Transplantation (HSCT).
Trial Details
NCT Number NCT03983369
Lead Sponsor Gustave Roussy, Cancer Campus, Grand Paris
Conditions
(from sponsor)
Mucositis Oral
Related terms Stomatitis
Enrollment 315 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov